Urticaria, commonly known as hives, forms the second‑largest demand driver for the india otc antihistamine 2029 market, contributing an estimated 30 % of total sales. The condition is characterized by transient, pruritic wheals that frequently arise from food allergens, insect bites, or stress‑related triggers. Because episodes are often acute and self‑limiting, patients typically seek immediate relief through OTC oral antihistamines rather than pursuing clinical evaluation. The segment benefits from a well‑established product line that includes second‑generation agents with reduced sedation, which are preferred by working‑age consumers concerned about productivity loss. Seasonal variations have a lesser impact than in allergic rhinitis, resulting in a more stable, year‑round demand pattern. Retail channels such as kirana stores and online marketplaces play a pivotal role in accessibility, while promotional activities focus on educating consumers about dosage frequency and safety profiles. These dynamics collectively sustain the urticaria application as a critical pillar of market taxonomy.
